Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid MalignanciesClinical Pharmacokinetics, 2020, 59 (9), pp.1171-1183. ⟨10.1007/s40262-020-00884-0⟩
Journal articles
hal-02989879v1
|
||
|
Interest of Dosing of Ibrutinib in B-Cell Lymphoid Malignancies: Data from a Real-Life, Phase 4 StudyBlood, 2018, 132 (Supplement 1), pp.3960-3960. ⟨10.1182/blood-2018-99-116532⟩
Journal articles
hal-02348092v1
|
||
|
Sphingosine kinase-1 is overexpressed and correlates with hypoxia in osteosarcoma: relationship with clinicopathological parametersCancers, 2022, 14 (3), pp.499. ⟨10.3390/cancers14030499⟩
Journal articles
hal-03312272v2
|